期刊文献+

胰岛素对牛胸主动脉内皮细胞血管内皮生长因子受体表达的影响及其与一氧化氮合酶活性的关系

Effect of insulin on expression of VEGF receptor (flt-1、flk-1/KDR) protein in serum-free cultured bovine thoracic aortic endothelial cells and its relation to the NOS_3 activation of endothelium
下载PDF
导出
摘要 目的 评价胰岛素对培养的牛胸主动脉内皮细胞血管内皮生长因子 (VEGF)受体flt 1、flk 1 KDR表达的影响及其与一氧化氮合酶 (NOS)的关系。方法 取新生的小牛胸主动脉 ,作血管内皮细胞原代及传代培养 ,取 4 6代培养细胞用于实验 ;应用不同浓度 ( 30mU L、30 0mU L、30 0 0mU L)的胰岛素和NOS抑制剂 (L NAME)干预培养过程 ,4 8h后取培养细胞 ,应用免疫组化法测定flt 1、flk 1 KDR和NOS3的表达水平。结果 不同浓度胰岛素孵育组后内皮细胞flt 1、flk 1 KDR的表达水平差异无显著性 ,L NAME孵育后各组内皮细胞flt 1、flk 1 KDR的表达水平较单纯胰岛素孵育组差异无显著性。结论 胰岛素对内皮细胞flt 1、flk 1 KDR的表达无直接影响 ;内皮细胞NOS3的活性不是内皮细胞VEGF受体flt 1、flk 1 Objective To investigate the expression of VEGF receptor (flt 1? flk 1/KDR) protein by cultured bovine thoracic aortic endothelial cells at various insulin concentrations and its relation to the NOS 3 activation of endothelium Methods Endothelial cells were separated from bovine thoracic aorta, and cultured in serum free medium, then incubated at various insulin concentrations (30 mU/L?300 mU/L?3?000 mU/L) and the NOS inhibitor L NAME (2 mmol/L) The levels of VEGF receptor (flt 1?flk 1/KDR) and NOS 3 protein were detected by use of immunohistochemical staining Results The expression of VEGF receptor (flt 1?flk 1/KDR) protein in bovine thoracic aortic endothelial cells had no significant difference ( P >0 05) between the insulin incubation groups both with and without L NAME incubations Conclusion Insulin has no direct effect on the expression of VEGF receptor (flt 1? flk 1/KDR) protein in bovine thoracic aortic endothelial cells The NOS 3 activation of endothelium is not the main cause that could affect the expression of VEGF receptor (flt 1?flk 1/KDR) protein of endothelium
出处 《中国介入心脏病学杂志》 2004年第2期111-114,共4页 Chinese Journal of Interventional Cardiology
关键词 胰岛素 胸主动脉 内皮细胞 血管内皮生长因子 受体表达 一氧化氮合酶 VEGF Insulin Flt 1 Flk 1/KDR Endothelial cell NOS 3
  • 相关文献

参考文献7

  • 1[1]Laws A, Reaven GM. Insulin resistance and risk factors for coronary heart disease. In: Ferrannini E. Clinical endocrinology and metabolism. London: Bailliere Tindall, 1993.1063-1078. 被引量:1
  • 2[2]Melidonis A, Tournis S, Kouvaras G, et al. Comparison of coronary collateral circulation in diabetic and nondiabetic patients suffering from coronary artery disease. Clin Cardiol, 1999,22:465-471. 被引量:1
  • 3[3]Murohara T, Horowitz JR, Silverm M. Vascular endothelial growth factor/VPE enhances vascular permeability via nitric oxide and prostacyclin. Circulation, 1998,97:99-107. 被引量:1
  • 4[4]Friedlander M, Brooks PC, Shaffer RW, et al. Definition of two angiogenic pathwaysby distinct alpha (Ⅴ) integrins. Science, 1995,270:1500-1502. 被引量:1
  • 5[5]Chou E, Suzuma I, Kerrie JW, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin -resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation, 2002,105:373-379. 被引量:1
  • 6[6]Steinberg HO, Chaker H, Leamin R, et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest, 1996,97:2601-2610. 被引量:1
  • 7[7]Yamagishi S, Kawakami T, Fujimori H, et al. Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Microvasc Res, 1999,57:329-339. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部